Technical Analysis for DAWN - Day One Biopharmaceuticals, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Up | Up | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Pocket Pivot | Bullish Swing Setup | 5.43% | |
Calm After Storm | Range Contraction | 5.43% | |
NR7 | Range Contraction | 5.43% | |
Upper Bollinger Band Walk | Strength | 5.43% | |
Above Upper BB | Strength | 5.43% | |
Up 3 Days in a Row | Strength | 5.43% | |
Up 4 Days in a Row | Strength | 5.43% | |
Upper Bollinger Band Touch | Strength | 5.43% | |
Pocket Pivot | Bullish Swing Setup | 7.68% | |
Calm After Storm | Range Contraction | 7.68% |
Alert | Time |
---|---|
Possible Pocket Pivot | about 3 hours ago |
Up 5% | about 5 hours ago |
Up 1 ATR | about 5 hours ago |
60 Minute Opening Range Breakout | about 6 hours ago |
Rose Above Previous Day's High | about 6 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 10/30/2024
Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed/progressive low-grade glioma. The company is also developing Pimasertib, an oral small molecule inhibitor of mitogen-activated protein kinase kinases 1 and 2. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in South San Francisco, California.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Cancer Enzymes Signal Transduction Protein Kinase Inhibitor Protein Kinase Kinase
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Cancer Enzymes Signal Transduction Protein Kinase Inhibitor Protein Kinase Kinase
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 18.0699 |
52 Week Low | 10.9 |
Average Volume | 1,048,078 |
200-Day Moving Average | 14.64 |
50-Day Moving Average | 14.29 |
20-Day Moving Average | 14.74 |
10-Day Moving Average | 14.84 |
Average True Range | 0.74 |
RSI (14) | 68.35 |
ADX | 30.66 |
+DI | 30.37 |
-DI | 9.17 |
Chandelier Exit (Long, 3 ATRs) | 14.02 |
Chandelier Exit (Short, 3 ATRs) | 15.63 |
Upper Bollinger Bands | 15.58 |
Lower Bollinger Band | 13.89 |
Percent B (%b) | 1.11 |
BandWidth | 11.47 |
MACD Line | 0.29 |
MACD Signal Line | 0.18 |
MACD Histogram | 0.1013 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 16.78 | ||||
Resistance 3 (R3) | 16.79 | 16.47 | 16.61 | ||
Resistance 2 (R2) | 16.47 | 16.21 | 16.46 | 16.55 | |
Resistance 1 (R1) | 16.11 | 16.05 | 16.29 | 16.10 | 16.50 |
Pivot Point | 15.79 | 15.79 | 15.88 | 15.78 | 15.79 |
Support 1 (S1) | 15.43 | 15.53 | 15.61 | 15.42 | 15.02 |
Support 2 (S2) | 15.11 | 15.37 | 15.10 | 14.97 | |
Support 3 (S3) | 14.75 | 15.11 | 14.91 | ||
Support 4 (S4) | 14.74 |